FDA NDC Directory · JSON-LD · Markdown

Oxaliplatin

NDC 68083-314 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerGland Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA207325
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsOXALIPLATIN (5 mg/mL)
Marketing started20171106
Package count1

External sources

Source: openFDA. Public-domain (CC0).